Showing results (1221-1230 of 2,132) with videos related to
Sort By:
Pageof 214
Biopharmaceutics & Drug Disposition|March 1, 1988
Effect of poisoning by soman (pinacolyl methylphosphonofluoridate) on the serum half-life of the cholinesterase reactivator HI-6 in miceJ G Clement, K J Simons, C J BriggsBiopharmaceutics & Drug Disposition|March 31, 2011
Higher clearance of micafungin in neonates compared with adults: role of age-dependent micafungin serum bindingSouzan B Yanni, P Brian Smith, Daniel K Benjamin, et al.Biopharmaceutics & Drug Disposition|March 19, 2011
Pancreatoduodenectomy as a source of human small intestine for Ussing chamber investigations and comparative studies with rat tissueIain S Haslam, Derek A O'Reilly, David J Sherlock, et al.Biopharmaceutics & Drug Disposition|February 23, 2011
Compliance descriptors: analysis and evaluation in terms of therapeutic effectSarem Sarem, Jun Li, Fahima NekkaBiopharmaceutics & Drug Disposition|February 23, 2011
Pharmacokinetics of a combination of Δ9-tetrahydro-cannabinol and celecoxib in a porcine model of hemorrhagic shockPavan K Vaddady, Nitin Mehrotra, Xiaofeng Zhang, et al.Biopharmaceutics & Drug Disposition|February 23, 2011
1α,25-dihydroxyvitamin D3 on intestinal transporter function: studies with the rat everted intestinal sacHan-Joo Maeng, Matthew R Durk, Edwin C Y Chow, et al.Biopharmaceutics & Drug Disposition|October 1, 2009
Effect of itraconazole on the pharmacokinetics of everolimus administered by different routes in ratsAkira Yokomasu, Ikuko Yano, Eriko Sato, et al.Biopharmaceutics & Drug Disposition|June 26, 2010
Binding of licarbazepine enantiomers to mouse and human plasma proteinsAna Fortuna, Gilberto Alves, Amílcar Falcão, et al.Biopharmaceutics & Drug Disposition|July 13, 2010
The prediction of human response to ONO-4641, a sphingosine 1-phosphate receptor modulator, from preclinical data based on pharmacokinetic-pharmacodynamic modelingTomoya Ohno, Chihiro Hasegawa, Susumu Nakade, et al.Biopharmaceutics & Drug Disposition|June 17, 2011
Differential pharmacokinetic analysis of in vivo erythropoietin receptor interaction with erythropoietin and continuous erythropoietin receptor activator in sheepMohammed H El-Komy, Robert L Schmidt, John A Widness, et al.Pageof 214